Literature DB >> 23429710

Immunosuppressive biological mechanisms support reassessment of use of the injectable contraceptive medroxyprogesterone acetate.

Janet P Hapgood1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23429710     DOI： 10.1210/en.2013-1066

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  10 in total

Review 1.  Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.

Authors:  Janet P Hapgood; Charu Kaushic; Zdenek Hel
Journal:  Endocr Rev       Date:  2018-02-01       Impact factor: 19.871

2.  Depot medroxyprogesterone acetate administration alters immune markers for HIV preference and increases susceptibility of peripheral CD4+ T cells to HIV infection.

Authors:  Carley Tasker; Amy Davidow; Natalie E Roche; Theresa L Chang
Journal:  Immunohorizons       Date:  2017-11-01

3.  Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.

Authors:  Richard P H Huijbregts; Katherine G Michel; Zdenek Hel
Journal:  Contraception       Date:  2014-02-26       Impact factor: 3.375

4.  Effect of hormonal contraception on the function of plasmacytoid dendritic cells and distribution of immune cell populations in the female reproductive tract.

Authors:  Katherine G Michel; Richard P H Huijbregts; Jonathan L Gleason; Holly E Richter; Zdenek Hel
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-15       Impact factor: 3.731

5.  Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent manner.

Authors:  Renate Louw-du Toit; Janet P Hapgood; Donita Africander
Journal:  J Biol Chem       Date:  2014-09-08       Impact factor: 5.157

6.  Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.

Authors:  Irina A Zalenskaya; Neelima Chandra; Nazita Yousefieh; Xi Fang; Oluwatosin E Adedipe; Suzanne S Jackson; Sharon M Anderson; Christine K Mauck; Jill L Schwartz; Andrea R Thurman; Gustavo F Doncel
Journal:  J Clin Invest       Date:  2018-09-17       Impact factor: 14.808

7.  The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor.

Authors:  Michele Tomasicchio; Chanel Avenant; Andrea Du Toit; Roslyn M Ray; Janet P Hapgood
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

8.  The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor.

Authors:  Yashini Govender; Chanel Avenant; Nicolette J D Verhoog; Roslyn M Ray; Nicholas J Grantham; Donita Africander; Janet P Hapgood
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

9.  Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission.

Authors:  Lyndsey R Buckner; Erma Z Drobnis; Molly S Augustine; Lynette K Rogers; Jill Akers; Patricia D Mott; Thomas J Hope; Alison J Quayle; Danny J Schust
Journal:  PLoS One       Date:  2019-05-16       Impact factor: 3.240

10.  The Injectable Contraceptive Medroxyprogesterone Acetate Attenuates Mycobacterium tuberculosis-Specific Host Immunity Through the Glucocorticoid Receptor.

Authors:  Michele Tomasicchio; Malika Davids; Anil Pooran; Grant Theron; Liezel Smith; Lynn Semple; Richard Meldau; Janet Patricia Hapgood; Keertan Dheda
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.